USPTO serial 79153435
KRYXANA
Reviewed by CopyMark Law Group
Reg. 4697841Status 404
- Filing date
- Status date
- Registration date
- Mar 10, 2015
- Examiner
- POLZER, NATALIE M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with KRYXANA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 21, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Oct 17, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 19, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 19, 2022 | INPC | INVALIDATION PROCESSED | — |
| Jul 26, 2022 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| Jun 5, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 20, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 20, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 9, 2015 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Mar 10, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 23, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 19, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 3, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 3, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 3, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 13, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 12, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 24, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 20, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 17, 2014 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 16, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |